-
Fibrates: Generally safe, but do they improve outcomes? According to this meta-analysis, the answer to the question above very much depends upon which outcome you believe is important.
-
-
Get ready to add another option to the list of emergency contraception (EC) methods. The Food and Drug Administration has approved ella (ulipristal acetate, UPA) tablets.
-
While vaginitis usually is considered a minor nuisance, many women experience chronic symptoms that persist or recur after treatment. What can clinicians do?
-
Good news! Scientists have discovered two potent human antibodies that can neutralize more than 90% of known global HIV strains from infecting human cells in the laboratory, and they have demonstrated how one of these disease-fighting proteins achieves this action.
-
-
Your next patient is a recently divorced 48-year-old mother of two. Her menstrual periods have become somewhat irregular, and she reports occasional hot flashes and night sweats.
-
The search for a female-controlled form of HIV prevention just took a giant step. Results of a Phase IIB trial of a tenofovir gel indicate that use of the gel before and after sex provided moderate protection against sexually transmitted HIV.
-
With a coordinated double-whammy, The Joint Commission and a group of quality experts, including current president, Mark R. Chassin, MD, MPP, MPH, have served notice on the QI community that they'd like things to change in a major way.
-
Patients at Duke University Hospital's cancer clinics have begun using electronic tablets to complete questionnaires about their health situation, and staffers are extremely pleased with the results.
